COPD treatment - a conceptual review based on critical endpoints.

Roque, A; Taborda-Barata, L; Cruz, Á A; Viegi, G; Maricoto, T

Roque, A; Taborda-Barata, L; Cruz, Á A; Viegi, G; Maricoto, T.

Afiliación

Roque A; Santa Joana Family Health Unit, Aveiro Health Centre, Aveiro, Portugal; University of Aveiro, Aveiro, Portugal.
Taborda-Barata L; UBIAir - Clinical & Experimental Lung Centre, UBIMedical, University of Beira Interior, Covilhã, Portugal; CICS- Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal; Department of Immunoallergology, Cova da Beira University Hospital Centre, Covilhã, Portugal.
Cruz ÁA; Fundação ProAR, Federal University of Bahia and GARD/WHO Planning Group, Salvador, Bahia, Brazil.
Viegi G; Institute of Clinical Physiology (IFC) - National Research Council (CNR), Pisa, Italy.
Maricoto T; UBIAir - Clinical & Experimental Lung Centre, UBIMedical, University of Beira Interior, Covilhã, Portugal; CICS- Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal; Beira Ria Health Center, Aveiro Health Centre, Ílhavo, Portugal; Faculty of Health Sciences, Universi

Pulmonology ; 29(5): 410-420, 2023.

Article en En | MEDLINE | ID: mdl-37030998

Asunto(s)

Eosinófilos; Enfermedad Pulmonar Obstructiva Crónica; Humanos; Administración por Inhalación; Recuento de Leucocitos; Corticoesteroides/uso terapéutico; Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico

Palabras clave

COPD; Eosinophils; Exacerbations; Inhaled therapy; Mortality; Therapeutics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Eosinófilos Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Pulmonology Año: 2023 Tipo del documento: Article País de afiliación: Portugal

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google